Jw. Huffman et al., 3-(1 ',1 '-dimethylbutyl)-1-deoxy-Delta(8)-THC and related compounds: Synthesis of selective ligands for the CB2 receptor, BIO MED CH, 7(12), 1999, pp. 2905-2914
The synthesis and pharmacology of 15 1-deoxy-Delta(8)-THC analogues, severa
l of which have high affinity for the CB2 receptor, are described. The deox
y cannabinoids include 1-deoxy-11-hydroxy-Delta(8)-THC (5), 1-deoxy-Delta(8
)-THC (6), 1-deoxy-3-butyl-Delta(8)-THC (7), 1-deoxy-3-hexyl-Delta(8)-THC (
8) and a series of 3-(1',1'-dimethylalkyl)-1-deoxy-Delta(8)-THC analogues (
2, n= 0-4, 6, 7, where n=the number of carbon atoms in the side chain-2). T
hree derivatives (17-19) of deoxynabilone (16) were also prepared. The affi
nities of each compound for the CB1 and CB2 receptors were determined emplo
ying previously described procedures. Five of the 3-(1',1'-dimethylalkyl)-1
-deoxy-Delta(8)-THC analogues (2, n = 1-5) have high affinity (K-i = < 20 n
M) for the CB2 receptor. Four of them (2, n= 1-4) also have little affinity
for the CB1 receptor (K-i = > 295 nM). 3-(1',1'-Dimethylbutyl)-1-deoxy-Del
ta(8)-THC (2, n = 2) has very high affinity for the CB2 receptor (K-i = 3.4
+/- 1.0 nM) and little affinity for the CB1 receptor (K-i = 677 +/- 132 nM
). (C) 1999 Elsevier Science Ltd. All rights reserved.